Medicamen Biotech Limited (MEDICAMEQ.NS) NSE

272.70

+2.6(+0.96%)

Updated at June 02 03:28PM

Currency In INR

Valuation

Market Cap2.98B
Enterprise Value3.15B
P/E Ratio29.52
PEG Ratio1.55
Price/Sales Ratio1.87
Price/Book Ratio1.16
Enterprise/Revenue1.95
Enterprise/EBITDA18.91

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.05
Operating Margin0.06

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue1.98B
Revenue/Share168.19
Gross Profit540.86M
EBITDA195.87M
Net Income96.41M
Diluted EPS7.22

Balance Sheet

Total Cash312.64M
Total Cash/Share26.59
Total Debt477.84M
Total Debt/Equity0.17
Current Ratio2.54
Book Value Per Share234.33

Price History

52-Week Change-34.8
52-Week High448.8
52-Week Low216.95
Moving Average 50 Days258.84
Moving Average 200 Days328.27

Statistics

Average Volume34,916
Shares Outstanding13.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield0.37
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A